Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae.

Published in: Therapeutic advances in infectious disease (2019)

Fosfomycin may be a valid option for oral treatment of cUTIs caused by ESBL-producing pathogens. The optimal duration of fosfomycin treatment for cUTIs remains to be determined.

Keyphrases

urinary tract infection
escherichia coli
gram negative
cystic fibrosis